SSA
AHCO icon

Schonfeld Strategic Advisors’s AdaptHealth AHCO Stock Holding History

Schonfeld Strategic Advisors’s Portfolio AHCO Stock Details AHCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-23,400
Closed -$254K – 2000
2025
Q1 		$254K Buy
+23,400
New +$235K ﹤0.01% 1855
2023
Q1 		– Sell
-23,469
Closed -$451K – 2059
2022
Q4 		$451K Sell
23,469
-10,204
-30% -$216K ﹤0.01% 1587
2022
Q3 		$633K Buy
+33,673
New +$692K 0.01% 1583
2022
Q1 		– Sell
-22,660
Closed -$554K – 2559
2021
Q4 		$554K Buy
22,660
+8,960
+65% +$210K 0.01% 1208
2021
Q3 		$319K Buy
+13,700
New +$331K ﹤0.01% 1494

Other funds holding AHCO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
OCA
OEP Capital Advisors New York $194M AUM 9.78% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SC
SkyKnight Capital San Francisco, California $107M AUM 9.69% 1-Year Est. Return
RP
Reinhart Partners Mequon, Wisconsin $4.38B AUM 55.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
JFG
Jefferies Financial Group New York $14.6B AUM 40.95% 1-Year Est. Return
SBH
Segall Bryant & Hamill Chicago, Illinois $6.98B AUM 34.78% 1-Year Est. Return

Schonfeld Strategic Advisors's AHCO Position: Q2 2025 in Review

Schonfeld Strategic Advisors sold out of AdaptHealth (AHCO) in Q2 2025, closing a stake of 23,400 shares — an estimated $254K sold.

Schonfeld Strategic Advisors first reported a position in AHCO in Q3 2021 and held it in 5 quarters. The position peaked at $633K in Q3 2022. 218 funds tracked by Wall St. Rank hold AHCO as of Q2 2025.

  • Schonfeld Strategic Advisors reported no remaining AdaptHealth position as of Q2 2025 after selling out during the quarter.
  • Schonfeld Strategic Advisors sold 23,400 AdaptHealth shares in Q2 2025, an estimated $254K.
  • Schonfeld Strategic Advisors first reported a position in AdaptHealth in Q3 2021 and held it in 5 quarters.
  • Schonfeld Strategic Advisors's AdaptHealth position peaked at $633K in Q3 2022.
  • 218 funds tracked by Wall St. Rank held AdaptHealth as of Q2 2025.

Based on Schonfeld Strategic Advisors's 13F filing for Q2 2025, filed 14 Aug 2025.